Healthcare -
Biotechnology - NYSE - DK
$ 78.69
-5.27 %
$ 349 B
Market Cap
26.86
P/E
NVO - COST OF REVENUE
Cost of Revenue NVO - Novo Nordisk A/S
35.8 B
LAST VALUE
22.95%
2 YEAR CAGR
15.21%
5 YEAR CAGR
9.72%
10 YEAR CAGR